Once again, the annual ritual is upon us.
Whilst this time of year often marks the beginning of present wrapping, Christmas carols, and an abundance of candy canes, it also signifies another yearly occurrence – the tax extender period. As observed in previous years, December denotes the start of Congress preparing to craft a bill which will extend circa 50 tax-reducing policies that expire each year. However, is this the year Congress will play Santa and give the gift of a permanent research and development (R&D) tax credit?
Certainly, the United States is not short
of advocators for permanency of the R&D Tax Credit scheme. In fact, many have long insisted the U.S. Congress to legislate a permanent R&D tax credit – or at minimum a multi-year extension, not just the typical provisional, one-year deals. Supporters of a permanent credit cite the fact that businesses struggle to rely on the temporary nature of the current credit in business and investment planning. Whereas, a permanent credit would give companies the assurance to participate in R&D, counterbalance the cost of innovation and level the playing field for high-paying jobs that embolden the U.S. economy.
However, if reports about the imminent legislation are accurate, the bill will fall short of accomplishing meaningful policy improvements. Since its inception as a temporary provision in 1981, the federal R&D tax credit has been extended 15 times, typically in one- or two-year increments, and is habitually permitted to expire before being extended retroactively. Adversaries believe the cost of extending the tax break to be permanent would cost more than $180 billion over a decade, according to the Joint Committee on Taxation.
On the other hand, news that the UK, France, India, Brazil, China and many other countries have recently improved their R&D incentives has heightened support for permanency in order to prevent the U.S. from falling behind in a highly competitive global landscape. As has been noted above, the R&D credit is a major driver of entrepreneurial activity and high-paying jobs. Companies generally assume Congress will renew the credit, as they have previously, yet the uncertainty around the timing and length of a renewal can pose challenges in earnings reporting and financial forecasts. Hence, a permanent credit could certainly assist in removing doubt and encouraging R&D investment.
Regardless, as of this writing, Congress leaders have not specified whether or not they will extend the R&D Credit. Hence, as per the past, the proverbial ‘last minute’ has arrived and if the Congress delivers a permanent or extension of the R&D credit is yet to be known.
Nonetheless, investments in research drive productivity advances and economic growth, and the research credit is vital to guaranteeing that those investments are completed here in the U.S. Therefore, due to the beneficial elements of R&D, it is still recommended companies engage in R&D activities. In relation to this, Swanson Reed is a specialist R&D tax firm who will be able to help you with claiming tax benefits under the scheme – albeit if it is permanent or not. If you want to learn more, contact us today to talk to one of our specialist R&D experts.
When the phrase “start-ups in Texas” is mentioned, the city of Austin is typically the first place that may come to mind. Indeed, Austin does have a thriving start-up culture, one that frequently ranks highly on voguish start up hubs list. However, merely 200 miles northeast exists one of the United States’ largest business networks, base to 18 Fortune 500 company headquarters and where 25 billionaires call home.
Whilst eating insects remains an oddity in the United States, Blueshift Research’s March 2015 Trend Tracker found that one-third of respondents were likely to buy an insect-based product. Moreover, insects are actually a consistent portion of the diet for more than two billion people around the world, according to a 2013 report from the Food and Agriculture Organization (FAO) of The United Nations. The report highlights the benefits of edible insects and how they can combat problems such as “the rising cost of animal protein, food and feed insecurity, environmental pressures, population growth and increasing demand for protein among the middle classes.”
Smoked, battered, fried or raw – fish do indeed come in many different culinary compositions. However, there is one form that may not delight the gastronomic folk: Invisible.
No, this isn’t a pitch for the next Hollywood blockbuster, but rather a summary of the research being undertaken in Texas. In specific, a collection of University of Texas researchers believe they could unravel new treatments for alcohol abuse by constructing a “supermouse” mutant that cannot get drunk. Research, such as this, could be extremely helpful given the difficulty in treating alcohol-related disorders. Currently, scientists are still uncertain on the molecular mechanisms involved in intoxication and withdrawal. Hence, current therapies to treat alcohol-related disorders remain wholly ineffective.
From pineapple embellished cakes and pizzas to salads and piña coladas – there is no denying that the humble tropical fruit is a versatile one. In fact, in the agricultural network pineapples are more than just a delicious refreshment, they are also prominent water-savers that may help feed the world.
To clarify, the researchers found that originally humans did not consume the genus Cucurbita—i.e., pumpkins, squash, and gourds—since it was bitter and toxic to humans and smaller animals. However, mastodons and other large herbivores, would eat these wild fruits and then discard the seeds through the terrestrial in their droppings. Thus, new squash and gourd plants would propagate, the megafauna would eat the fruit, and the entire cycle would endure. However, when humans arrived in America between 13,500 and 14,500 years ago, overhunting, along with a shifting climate, eliminated giant sloths and their kin. Hence, without human intervention, our cherished fall pumpkin treats would have gone with them.
exas-based researchers, Cheulhee Jung, Peter B. Allen and Andrew Ellington, have created a nanoscale machine that can randomly walk in any direction across uneven surfaces. Future applications of such a DNA walker are predicted to be a cancer detector that could circulate the human body examining for cancerous cells and tagging them for medical imaging or drug targeting.